Literature DB >> 12445162

Muscle pathology in dysferlin deficiency.

M Fanin1, C Angelini.   

Abstract

Dysferlin deficiency is being increasingly recognized in limb-girdle dystrophy and distal myopathy but its role in the development of muscle pathology is still poorly understood. For this purpose, 26 muscle biopsies from 25 dysferlinopathy patients were analysed by routine histochemistry and by immunohistochemistry with eight different antibodies, and scored for inflammatory response and type of cell infiltrate, fibre degeneration and regeneration, fibre type composition and severity of histopathological changes. In cases with an advanced-stage dystrophic pattern we observed type 1 fibre predominance exceeding 80%, suggesting a selective loss of type 2 fibres or a conversion process. The extent of muscle fibre regeneration and degeneration in dysferlinopathy was intermediate between sarcoglycanopathy and Duchenne dystrophy or myositis, suggesting a rather aggressive course of the disease. An increased inflammatory response was observed in the majority of our patients (16/26), who also showed an active dystrophic pattern. Type and localization of cellular infiltrates suggest that inflammatory reaction is secondary to necrosis. Major histocompatibility complex (MHC) class I molecules were overexpressed in dysferlinopathy, mainly in association with fibre phagocytosis and regeneration; their occasional expression in non-necrotic fibres might represent a marker of ongoing necrosis. Muscle inflammation might be triggered by the structurally altered membrane consequent to dysferlin defect.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12445162     DOI: 10.1046/j.1365-2990.2002.00417.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  35 in total

1.  Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy.

Authors:  Alberto Lerario; Filippo Cogiamanian; Chiara Marchesi; Marzia Belicchi; Nereo Bresolin; Laura Porretti; Yvan Torrente
Journal:  BMC Musculoskelet Disord       Date:  2010-07-11       Impact factor: 2.362

2.  CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathy.

Authors:  Xi Yin; Qian Wang; Ting Chen; Junwei Niu; Rui Ban; Jiexiao Liu; Yanling Mao; Chuanqiang Pu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 3.  Myositis Mimics.

Authors:  E Harlan Michelle; Andrew L Mammen
Journal:  Curr Rheumatol Rep       Date:  2015-10       Impact factor: 4.592

Review 4.  Which nonautoimmune myopathies are most frequently misdiagnosed as myositis?

Authors:  Andrew L Mammen
Journal:  Curr Opin Rheumatol       Date:  2017-11       Impact factor: 5.006

5.  Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I.

Authors:  A Palmieri; R Manara; L Bello; G Mento; L Lazzarini; C Borsato; L Bortolussi; C Angelini; E Pegoraro
Journal:  J Neurol       Date:  2011-02-04       Impact factor: 4.849

6.  Muscle MRI findings in facioscapulohumeral muscular dystrophy.

Authors:  Simonetta Gerevini; Marina Scarlato; Lorenzo Maggi; Mariangela Cava; Giandomenico Caliendo; Barbara Pasanisi; Andrea Falini; Stefano Carlo Previtali; Lucia Morandi
Journal:  Eur Radiol       Date:  2015-06-27       Impact factor: 5.315

7.  Characterization of novel CAPN3 isoforms in white blood cells: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis.

Authors:  L Blázquez; M Azpitarte; A Sáenz; M Goicoechea; D Otaegui; X Ferrer; I Illa; E Gutierrez-Rivas; J J Vilchez; A López de Munain
Journal:  Neurogenetics       Date:  2008-06-19       Impact factor: 2.660

8.  Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation.

Authors:  Joseph J Belanto; Silvia V Diaz-Perez; Clara E Magyar; Michele M Maxwell; Yasemin Yilmaz; Kasey Topp; Guney Boso; Catriona H Jamieson; Nicholas A Cacalano; Christina A M Jamieson
Journal:  Neuromuscul Disord       Date:  2010-01-18       Impact factor: 4.296

9.  Quantitation of the calcium and membrane binding properties of the C2 domains of dysferlin.

Authors:  Nazish Abdullah; Murugesh Padmanarayana; Naomi J Marty; Colin P Johnson
Journal:  Biophys J       Date:  2014-01-21       Impact factor: 4.033

10.  Myogenesis in dysferlin-deficient myoblasts is inhibited by an intrinsic inflammatory response.

Authors:  Tatiana V Cohen; Jonathan E Cohen; Terence A Partridge
Journal:  Neuromuscul Disord       Date:  2012-05-03       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.